Break Through Cancer
Signal active
Investment Firm
Overview
Break Through Cancer empowers outstanding researchers and physicians to both intercept and find cures for the deadliest cancers by stimulating radical collaboration.
Highlights
Founded
2021
Industry
Product Research
Employees
0
Investment
5
Lead Investment
5
Exits
undefined
Stages
N/A
Investor Type
N/A
Location
Cambridge, Massachusetts, United States, North America
Contact Information
Social
Profile Resume
Break Through Cancer, established in 2021 and headquartered in United States, North America., specializes in investments across Biotechnology, Oncology, Education, Life Science, Health Care, Training, Hospital, Communities, Non Profit, Health Diagnostics. Their recent investments include Koch Institute for Integrative Cancer Research at MIT., Memorial Sloan - Kettering Cancer Center, Dana-Farber Cancer Institute. The highest investment round they participated in was $602.8M. Among their most notable exits are Koch Institute for Integrative Cancer Research at MIT. and Memorial Sloan - Kettering Cancer Center. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
Break Through Cancer has made 5 investments. Their most recent investment was on Apr 19, 2022, when Dana-Farber Cancer Institute raised $11.0M.
Break Through Cancer has made 1 diversity investments. Their most recent diversity investment was on Apr 19, 2022, when Memorial Sloan - Kettering Cancer Center raised $12.0M.
investments
5
Diversity investments
1
Lead investments
5
Number of exits
undefined
Investments
5
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Apr 19, 2022 | - | - | 10.0M |
| Apr 19, 2022 | Dana-Farber Cancer Institute | Communities | 11.0M |
| Apr 19, 2022 | Memorial Sloan - Kettering Cancer Center | Education | 12.0M |
| May 16, 2023 | - | - | 2.7M |
Memorial Sloan - Kettering Cancer CenterExits
0
Funding Timeline
Funding rounds
5
Investors
0
Funds
0
Funding Rounds
5
Break Through Cancer has raised 5 rounds. Their latest funding was raised on May 16, 2023 from a Grant - MD Anderson Cancer Center round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Apr 19, 2022 | Grant - MD Anderson Cancer Center | - | 10.0M | - |
| Apr 19, 2022 | Grant - Dana-Farber Cancer Institute | - | 11.0M | - |
| Apr 19, 2022 | Grant - Memorial Sloan - Kettering Cancer Center | - | 12.0M | - |
| May 16, 2023 | Grant - MD Anderson Cancer Center | - | 2.7M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
Funding Round
May 16, 2023
MD Anderson Cancer Center raised $2700000 on 2023-05-16 in Grant
Funding Round
Apr 19, 2022
Memorial Sloan - Kettering Cancer Center raised $12000000 on 2022-04-19 in Grant
Funding Round
Apr 19, 2022
Dana-Farber Cancer Institute raised $11000000 on 2022-04-19 in Grant
Funding Round
Apr 19, 2022
MD Anderson Cancer Center raised $10000000 on 2022-04-19 in Grant
Funding Round
Apr 11, 2022
Koch Institute for Integrative Cancer Research at MIT. raised $6000000 on 2022-04-11 in Grant